Zhuang H - Search Results

1

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy.

Zhuang H, Hou H, Yuan Z, Wang J, Pang Q, Zhao L, Wang P. Zhuang H, et al. Onco Targets Ther. 2014 May 24;7:807-13. doi: 10.2147/OTT.S62707. eCollection 2014. Onco Targets Ther. 2014. PMID: 24920921 Free PMC article.

2

Process in the mechanisms of endostatin combined with radiotherapy.

Zhuang HQ, Yuan ZY. Zhuang HQ, et al. Cancer Lett. 2009 Sep 8;282(1):9-13. doi: 10.1016/j.canlet.2008.12.008. Epub 2009 Jan 10. Cancer Lett. 2009. PMID: 19136200 Review.

3

Radiosensitizing effects of gefitinib at different administration times in vitro.

Zhuang HQ, Sun J, Yuan ZY, Wang J, Zhao LJ, Wang P, Ren XB, Wang CL. Zhuang HQ, et al. Cancer Sci. 2009 Aug;100(8):1520-5. doi: 10.1111/j.1349-7006.2009.01190.x. Epub 2009 May 4. Cancer Sci. 2009. PMID: 19432883 Free PMC article.

4

The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro.

Zhuang HQ, Wang J, Yuan ZY, Zhao LJ, Wang P, Wang CL. Zhuang HQ, et al. J Exp Clin Cancer Res. 2009 Sep 1;28(1):123. doi: 10.1186/1756-9966-28-123. J Exp Clin Cancer Res. 2009. PMID: 19723324 Free PMC article.

5

Research progress on criteria for discontinuation of EGFR inhibitor therapy.

Zhuang HQ, Yuan ZY, Wang J, Wang P, Zhao LJ, Zhang BL. Zhuang HQ, et al. Onco Targets Ther. 2012;5:263-70. doi: 10.2147/OTT.S36103. Epub 2012 Oct 15. Onco Targets Ther. 2012. PMID: 23082072 Free PMC article.

6

The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma.

Zhuang H, Wang J, Zhao L, Yuan Z, Wang P. Zhuang H, et al. Int J Cancer. 2013 Nov 15;133(10):2277-83. doi: 10.1002/ijc.28290. Epub 2013 Jun 21. Int J Cancer. 2013. PMID: 23720067 Review.

7

The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transduction.

Zhuang HQ, Bo QF, Yuan ZY, Wang J, Zhao LJ, Wang P. Zhuang HQ, et al. Onco Targets Ther. 2013 May 28;6:603-8. doi: 10.2147/OTT.S44505. Print 2013. Onco Targets Ther. 2013. PMID: 23745052 Free PMC article.

8

A comparison between cyberknife and neurosurgery in solitary brain metastases from non-small cell lung cancer.

Tian LJ, Zhuang HQ, Yuan ZY. Tian LJ, et al. Clin Neurol Neurosurg. 2013 Oct;115(10):2009-14. doi: 10.1016/j.clineuro.2013.06.006. Epub 2013 Jul 10. Clin Neurol Neurosurg. 2013. PMID: 23850045

9

Research progress on the mechanisms of combined bevacizumab and radiotherapy.

Zhuang HQ, Yuan ZY, Wang P. Zhuang HQ, et al. Recent Pat Anticancer Drug Discov. 2014 Jan;9(1):129-34. doi: 10.2174/15748928113089990044. Recent Pat Anticancer Drug Discov. 2014. PMID: 24032532 Review.

10

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma.

Zhuang H, Yuan Z, Wang J, Zhao L, Pang Q, Wang P. Zhuang H, et al. Drug Des Devel Ther. 2013 Oct 8;7:1179-86. doi: 10.2147/DDDT.S53011. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24133369 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,608 results

Search Page

Filters